| Literature DB >> 27341473 |
Tristan Martin1,2,3, Sébastien Moussay1,2,3, Ingo Bulla4,5, Jan Bulla6, Michel Toupet7, Olivier Etard3,8, Pierre Denise1,2,3,8, Damien Davenne1,2,3, Antoine Coquerel1,2,3,9, Gaëlle Quarck1,2,3.
Abstract
BACKGROUND: New insights have expanded the influence of the vestibular system to the regulation of circadian rhythmicity. Indeed, hypergravity or bilateral vestibular loss (BVL) in rodents causes a disruption in their daily rhythmicity for several days. The vestibular system thus influences hypothalamic regulation of circadian rhythms on Earth, which raises the question of whether daily rhythms might be altered due to vestibular pathology in humans. The aim of this study was to evaluate human circadian rhythmicity in people presenting a total bilateral vestibular loss (BVL) in comparison with control participants. METHODOLOGY AND PRINCIPALEntities:
Mesh:
Substances:
Year: 2016 PMID: 27341473 PMCID: PMC4920359 DOI: 10.1371/journal.pone.0155067
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Mean parameters of the circadian rhythms of the sleep wake cycle.
| Sleep/Wake cycle(count/min) | Patients | Control | |
|---|---|---|---|
| Acrophase (hh:mm) | 3:05PM ± 1:03h | 3:09PM ± 0:19h | 0.84 |
| Amplitude (count/min) | 0.86 ± 0.04 | 0.93 ± 0.03 | 0.004 |
| Mesor (count/min) | 193.11 ± 53.84 | 203.88 ± 45.6 | 0.68 |
Mean parameters of the circadian rhythms of the sleep/wake cycle calculated by the Non-Parametric Circadian Rhythm Analysis (NPCRA) method.
* indicates a significant difference with p<0.05.
Mean actigraphy parameters (M±SD for the whole week, weekdays and weekends.
| Whole week | Weekdays | Weekends | Weekdays vs weekends | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | Control | Patients | Control | Patients | Control | Patients | Control | ||||
| 201±49 | 201 ± 44 | 0.98 | 189 ± 56 | 195 ± 40 | 0.84 | 202 ± 54 | 218 ± 76 | 0.65 | 0.03 | 0.34 | |
| 266 ± 67 | 286 ± 61 | 0.55 | 250 ±73 | 277 ± 60 | 0.43 | 276 ± 76 | 308 ± 98 | 0.50 | 0.04 | 0.34 | |
| 63 ± 23 | 35 ± 23 | 0.03 | 63 ± 34 | 32 ± 17 | 0.04 | 47 ± 20 | 41 ± 42 | 0.76 | 0.23 | 0.42 | |
| 5 ± 2 | 12 ±8 | 0.04 | 5 ± 2 | 12 ± 9 | 0.06 | 7 ± 3 | 12 ± 9 | 0.15 | 0.09 | 0.99 | |
| 66 ± 8 | 62 ± 4 | 0.17 | 67 ± 8 | 61 ± 4 | 0.07 | 63 ± 7 | 61 ± 6 | 0.57 | 0.001 | 0.95 | |
| 85 ± 10 | 82 ± 4 | 0.17 | 87 ± 10 | 82 ± 4 | 0.27 | 81 ± 9 | 78 ± 8 | 0.49 | 0.01 | 0.32 | |
| 26 ± 8 | 21 ± 6 | 0.35 | 27 ± 9 | 21 ± 6 | 0.18 | 24 ± 8 | 20 ± 7 | 0.25 | 0.32 | 0.48 | |
The mean daily activity level over 24 h, during the habitual wake period and the habitual sleep period, were calculated. The ratio between sleep and wake period was thus estimated. The mean activity index (% of activity per hour) over 24 h, during the wake and sleep period, were also calculated. These parameters were calculated for the whole week, and separately for the weekends and the weekdays.
* indicates a significant difference with p<0.05.
Mean sleep parameters (M±SD) estimated by sleep analysis for the whole week, weekdays, and weekends.
| Sleep Parameters (M±SD) | Whole week | Weekdays | Weekends | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Patients | Controls | Patients | Controls | patients | Controls | ||||
| Wake time (00:00) | 07:16 ± 0:40h | 07:47 ± 0:40h | 0.18 | 06:56 ± 1:24h | 07:44 ± 0:52h | 0.19 | 07:10 ± 1:31h | 07:53 ± 1:00h | 0.28 |
| SO (00:00) | 0:00 ± 0:45h | 23:55PM ± 0:53h | 0.78 | 00:01PM ± 0:47h | 23:55PM± 0:36h | 0.75 | 23:58PM ± 0:53h | 23:51PM ± 0:59h | 0.82 |
| TST (h) | 06:16 ± 1:05 | 07:02 ± 1:11 | 0.22 | 06:14 ± 1:04 | 06:59 ± 1:08 | 0.22 | 06:22 ± 1:11 | 07:09 ± 1:23 | 0.27 |
| WASO (h) | 01:05 ± 0:27 | 00:50 ± 0:18 | 0.21 | 01:04 ± 0:26 | 00:49 ± 0:20 | 0.23 | 01:10 ± 0:32 | 00:51 ± 0:16 | 0.18 |
| SL (h) | 00:18 ± 0:13 | 00:12 ± 0:06 | 0.30 | 00:13 ± 0:10 | 00:13 ± 0:08 | 0.92 | 00:14 ± 0:07 | 00:09 ± 0:05 | 0.17 |
| SE (%) | 78.83 ± 6.86 | 85.35 ± 5.61 | 0.06 | 79.30 ± 6.53 | 86.05 ± 5.02 | 0.04 | 77.66 ± 9.29 | 85.13 ± 7.69 | 0.11 |
| bed time (00:00PM) | 11:42 ± 0:52h | 11:42 ± 0:39h | 0.99 | 11:44 ± 0:54h | 11:42 ± 0:33h | 0.93 | 11:38 ± 0:56h | 11:41 ± 0:59h | 0.91 |
| Rising up time (00:00AM) | 07:34 ± 0:43h | 07:59 ± 0:38h | 0.24 | 07:31 ± 0:41h | 07:52 ± 0:45h | 0.35 | 07:44 ± 0:57h | 08:14h ± 0:31 | 0.24 |
Sleep measurement for wake time, sleep onset (SO), total sleep time (TST), wake after sleep onset duration (WASO), sleep latency (SL), sleep efficiency (SE), bed time (00:00PM) and rising up time (00:00AM)
* indicates a significant difference with p<0.05.
Estimated parameters (intercept and slope) of salivary cortisol for control and patients.
| Type of model and parameters subject to a session effect | df | AIC | BIC | loglik | Test | LRT | |
|---|---|---|---|---|---|---|---|
| 1. Null model (mo) Group effect: none | 6 | 243.21 | 258.47 | -115.61 | 1 vs. 2 | 88.06 | |
| 2. Selected model (ms) Group effect: phase | 7 | 233.60 | 251.40 | -109.80 | 2 vs. 3 | 11.62 | |
| Value | SD | t-value | |||||
| Intercept | Control | 4.90 | 0.29 | 17.03 | < 0.001 | ||
| Δ patients | 0.74 | 0.18 | 4.13 | 0.001 | |||
| Slope | Control& patients | -0.18 | 0.015 | -12.49 | <0.001 |
The columns show (from left to right) the estimated parameter value, the standard deviation of the estimate (SD), the t-statistic, the t-value and the resulting p-value.
In order to take varying variability into account, based on AIC and BIC we selected a power variance function with different coefficients for the treatment and control group. The presence of residual within-subject autocorrelation was not supported.
In order to determine the best model fitting the data, we first built a model with constant intercept as basic model (m0). Then, we added step-wise a simple time trend, a group effect on the intercept, a group effect on the slope, and a group effect on both. The finally selected model (ms) has common slope for both treatment and control group, but varying intercept. Selection was supported by AIC, BIC, and LRT, which all showed clear preference compared to a simple linear regression (m0). The slope of 0.18 means that slivary cortisol was lowering by 0.18 pg/mL per hour
Fig 1Salivary cortisol levels.
Salivary cortisol profiles are shown for Patients (black) and Controls (grey). * indicates a significant effect of time of day. § indicates a significant difference between groups.
Mean parameters of the circadian rhythms of the salivary cortisol.
| Cortisol (pg/mL) | Patients | Control | |
|---|---|---|---|
| Acrophase (hh:mm) | 7:14AM ± 1:54h | 5:46AM ± 1:03h | 0.07 |
| Amplitude (pg/mL) | 3.76 ± 1.43 | 3.63 ± 0.77 | 0.82 |
| Mesor (pg/mL) | 3.64 ± 0.93 | 2.89 ± 0.38 | 0.053 |
Mean parameters of the circadian rhythms of salivary cortisol calculated by the COSINOR method.
* indicates a significant difference with p<0.05.
Fig 2Body Temperature curves.
Temperature COSINOR curves (blue) and smoothed curves by local polynomial regression (function “LOESS” in red) for Patients (upper pattern) and Control group (lower pattern). The solid blue lines corresponds to results from the estimated cosinor function The dashed lines around the solid line correspond to a confidence band of level for the estimated cosinor curve. Solid red lines result from local polynomial regression (with span parameter α = 0.25). As before, dashed red lines correspond to the borders of the confidence band of level . Thus, areas in which the two confidence bands do not overlap indicate a difference between the two functions with confidence level 95%. The highest and lowest values estimated by the LOESS method are respectively observed at 4:29 PM and 7:40 AM (although a nearly equally low minimum is already attained much earlier in the morning). The deviations were marginal since the local smoother mostly overlaps the COSINOR modeling only around 5:00 AM and 8:00 AM and around 4:00 PM and 7:00 PM. More precisely, the local smoother indicates that the temperature remains at a lower level than the COSINOR in the morning, with the largest difference attained at about 6:30 AM. In the following hours, the temperature rises faster than the COSINOR captures, and attains its steady state about 12:40 PM. In the following hours, the temperature remains relatively stable at a high level, roughly between 37.25 and 37.35°C. Then, in the evening at about 9:10 PM, the temperature drops, and the decline is stronger than the COSINOR is able to capture.
COSINOR analysis performed on all data for each group.
| Type of model and parameters subject to a session effect | df | AIC | BIC | loglik | Test | LRT | |
|---|---|---|---|---|---|---|---|
| 1. Null model (mo): COSINOR Group effect: none | 5 | -106533.0 | -106493.4 | 53271.49 | |||
| 2. selected model (ms): Extended COSINOR Group effect: phase | 6 | -106536.6 | -106489.1 | 53274.32 | 1 vs 2 | 5.661363 | |
| Mesor | 36.98 | 0.02 | 1830.09 | <0.001 | |||
| Amplitude | 0.68 | 0.024 | 14.57 | <0.001 | |||
| Acrophase | 17.49 | 0.37 | 47.53 | <0.001 | |||
| Δ Acophase patient vs. control | -1.22 | 0.51 | -2.40 | 0.016 | |||
The table displays data from the controls and patients. In order to investigate the potential presence of group effects, we fitted a cosinor function without group effect (i.e., the entire data). Inclusion of a group effect in the mesor, amplitude, and phase showed that a group effect in the phase is supported by a LRT (and AIC; but not BIC). Model m0 corresponds to the simple cosinor, ms cooresponds to a cosinor with group effect in the phase:
The parameters m, a, and p correspond to mesor, amplitude, and acrophase respectively. Δ Acrophase re present the shift of the acrophase of the patient group, The estimated acrophase of the control group takes value 17.489 (i.e., 17h29), whereas the acrophase of the patients is significantly advanced by -1.22 (i.e., 1h13).
Fig 3Body temperature rhythms and phase.
(A) Circadian rhythm of gastrointestinal temperature: Mean values (-) and SD (grey line) recorded every 60 s is shown for Patients (upper panel) and Controls (lower panel). The dashed blue lines represent modeling using the COSINOR method. Dark frame represents the sleeping period in the laboratory. (B) Individual acrophases of temperature in Controls (◇) and Patients (●). The 6.
Fig 4Timing between circadian rhythms and sleep.
Association between the timing of acrophase of temperature (h) and sleep onset (h) recorded during the 15-day actigraphy in Patients (upper panel) and in Controls (lower panel) groups.